These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

965 related items for PubMed ID: 23092878

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T, Robbins DC, Williams SJ, Novikova L, Stehno-Bittel L.
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [Abstract] [Full Text] [Related]

  • 3. Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo.
    Uhles S, Wang H, Bénardeau A, Prummer M, Brecheisen M, Sewing S, Tobalina L, Bosco D, Wollheim CB, Migliorini C, Sebokova E.
    Diabetes Obes Metab; 2011 Apr; 13(4):326-36. PubMed ID: 21205124
    [Abstract] [Full Text] [Related]

  • 4. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
    Iki K, Pour PM.
    J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic peptides in young and elderly Zucker type 2 diabetic fatty rats.
    Howarth FC, Al Kitbi MK, Hameed RS, Adeghate E.
    JOP; 2011 Nov 09; 12(6):567-73. PubMed ID: 22072245
    [Abstract] [Full Text] [Related]

  • 6. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
    Delghingaro-Augusto V, Décary S, Peyot ML, Latour MG, Lamontagne J, Paradis-Isler N, Lacharité-Lemieux M, Akakpo H, Birot O, Nolan CJ, Prentki M, Bergeron R.
    Am J Physiol Endocrinol Metab; 2012 Jan 15; 302(2):E254-64. PubMed ID: 22045312
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD, Lavery KS, Irwin N, O'harte FP, Harriott P, Greer B, Bailey CJ, Flatt PR.
    J Pharmacol Exp Ther; 2006 Aug 15; 318(2):914-21. PubMed ID: 16648370
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats.
    Janssen SW, Hermus AR, Lange WP, Knijnenburg Q, van der Laak JA, Sweep CG, Martens GJ, Verhofstad AA.
    Exp Clin Endocrinol Diabetes; 2001 Aug 15; 109(5):273-82. PubMed ID: 11507651
    [Abstract] [Full Text] [Related]

  • 11. Quantitative histopathological assessment of retardation of islets of langerhans degeneration in rosiglitazone-dosed obese ZDF rats using combined insulin and collagens (I and III) immunohistochemistry with automated image analysis and statistical modeling.
    Jones HB, Bigley AL, Pemberton J, Randall KJ.
    Toxicol Pathol; 2013 Aug 15; 41(3):425-44. PubMed ID: 23047688
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.
    Spijker HS, Song H, Ellenbroek JH, Roefs MM, Engelse MA, Bos E, Koster AJ, Rabelink TJ, Hansen BC, Clark A, Carlotti F, de Koning EJ.
    Diabetes; 2015 Aug 15; 64(8):2928-38. PubMed ID: 25918235
    [Abstract] [Full Text] [Related]

  • 15. Distinctions between the islets of mice and men: implications for new therapies for type 1 and 2 diabetes.
    Levetan CS, Pierce SM.
    Endocr Pract; 2013 Aug 15; 19(2):301-12. PubMed ID: 23186955
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model.
    Shang Q, Liu MK, Saumoy M, Holst JJ, Salen G, Xu G.
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr 15; 302(8):G815-23. PubMed ID: 22281473
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, Taiji M.
    Metabolism; 2006 Oct 15; 55(10):1286-92. PubMed ID: 16979397
    [Abstract] [Full Text] [Related]

  • 19. Exendin-4, a glucagon-like peptide-1 receptor agonist, suppresses pancreatic β-cell destruction induced by encephalomyocarditis virus.
    Sano H, Terasaki J, Mishiba Y, Imagawa A, Hanafusa T.
    Biochem Biophys Res Commun; 2011 Jan 21; 404(3):756-61. PubMed ID: 21144822
    [Abstract] [Full Text] [Related]

  • 20. Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models.
    Lehtonen J, Schäffer L, Rasch MG, Hecksher-Sørensen J, Ahnfelt-Rønne J.
    Islets; 2015 Jan 21; 7(6):e1137415. PubMed ID: 26963143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.